RhumbLine Advisers
ABCL icon

RhumbLine Advisers’s AbCellera Biologics ABCL Stock Holding History

RhumbLine Advisers’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-135
Closed -$301 – 4138
2025
Q1 		$301 Hold
135
– – ﹤0.01% 4074
2024
Q4 		$395 Hold
135
– – ﹤0.01% 4108
2024
Q3 		$351 Hold
135
– – ﹤0.01% 4133
2024
Q2 		$399 Hold
135
– – ﹤0.01% 4296
2024
Q1 		$611 Buy
+135
New +$689 ﹤0.01% 4179
2023
Q3 		– Sell
-9,393
Closed -$60.7K – 4309
2023
Q2 		$60.7K Sell
9,393
-291,062
-97% -$1.99M ﹤0.01% 3641
2023
Q1 		$2.27M Buy
300,455
+6,398
+2% +$58.1K ﹤0.01% 1736
2022
Q4 		$2.98M Buy
294,057
+6,545
+2% +$75.6K ﹤0.01% 1578
2022
Q3 		$2.84M Buy
287,512
+21,959
+8% +$241K ﹤0.01% 1573
2022
Q2 		$2.83M Buy
+265,553
New +$2.25M ﹤0.01% 1568

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return